Skip to content
Science in Public
  • About usExpand
    • Team
    • Clients
    • Portfolio
  • ServicesExpand
    • Prize nomination support
    • Writing and editing
    • Communication support
    • One-to-one consulting
    • Video production
    • Media for conferences
  • Media Training
  • Media releases
  • National Science WeekExpand
    • Get involved in 2026
    • Case studies
  • NewslettersExpand
    • For scientists
    • For journalists
Contact
Science in Public
  • Dr Josh Boyle from Boron Molecular working with a flow reactor
    Boron | Media releases

    Can we guarantee supply of essential drugs in a global crisis?

    30 March, 20216 July, 2021

    Flow chemistry trial will test new way to make drugs locally and fast Australia may soon be able to produce essential drugs – including anaesthetics and treatments for antibiotic resistant superbugs – rapidly and entirely onshore, ending the need to import them. A collaboration between Melbourne chemical company Boron Molecular and DMTC Ltd (formerly the…

    Read More Can we guarantee supply of essential drugs in a global crisis?Continue

© 2026 Science in Public - WordPress Theme by Kadence WP

Linkedin Facebook Instagram
  • About us
    • Team
    • Clients
    • Portfolio
  • Services
    • Prize nomination support
    • Writing and editing
    • Communication support
    • One-to-one consulting
    • Video production
    • Media for conferences
  • Media Training
  • Media releases
  • National Science Week
    • Get involved in 2026
    • Case studies
  • Newsletters
    • For scientists
    • For journalists
Search